NCT00103636

Brief Summary

The purpose of this study is to investigate the effects of extending the dwell time of peripheral intravenous cannulas on clinical outcomes and cost.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2004

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2004

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2004

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 14, 2005

Completed
Last Updated

June 24, 2005

Status Verified

February 1, 2005

First QC Date

February 11, 2005

Last Update Submit

June 23, 2005

Conditions

Phlebitis

Keywords

Phlebitis/etiologyInfusionsIntravenous/adverse effectsRandomised controlled trialPhlebitis/preventionAdultTime factors

Outcome Measures

Primary Outcomes (1)

  • Phlebitis during the course of the infusion and up to 48 hours after peripheral venous catheter removal

Secondary Outcomes (5)

  • Infiltration permeation of IV fluid into the interstitial compartment

  • Local infection at the site of the catheter

  • Catheter-related blood stream infection

  • Catheter colonization

  • Cost

Interventions

Extending peripheral intravenous (IV) cannula dwell timesPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients are eligible to join the Peripheral Venous Catheter Trial if:
  • They are inpatients at the Royal Brisbane and Royal Women's Hospital who are at least 18 years of age
  • AND
  • They are scheduled or expected to have a peripheral venous catheter indwelling for at least 4 days.
  • AND
  • They have had their catheter inserted by a nurse from the IV Therapy Team

You may not qualify if:

  • Patients with an existing bloodstream infection
  • Those receiving immunosuppressive treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Brisbane and Women's Hospital

Brisbane, Queensland, 4029, Australia

Location

MeSH Terms

Conditions

Phlebitis

Condition Hierarchy (Ancestors)

Peripheral Vascular DiseasesVascular DiseasesCardiovascular DiseasesVasculitis

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

February 11, 2005

First Posted

February 14, 2005

Study Start

March 1, 2004

Study Completion

December 1, 2004

Last Updated

June 24, 2005

Record last verified: 2005-02

Locations

AU(1)